277 related articles for article (PubMed ID: 11967570)
1. [New Drugs: Ectasy and Gamma-Hydroxy-Butyrate (GHB)].
Feldman N; Croquette-Krokar M
Vertex; 2002; 13(47):5-8. PubMed ID: 11967570
[TBL] [Abstract][Full Text] [Related]
2. [The new drugs: ecstasy, GHB. Update for practitioners].
Feldman N; Croquette-Krokar M
Rev Med Suisse Romande; 2001 Dec; 121(12):885-8. PubMed ID: 11803792
[No Abstract] [Full Text] [Related]
3. A brief overview of the clinical pharmacology of "club drugs".
Britt GC; McCance-Katz EF
Subst Use Misuse; 2005; 40(9-10):1189-201. PubMed ID: 16048813
[TBL] [Abstract][Full Text] [Related]
4. Recent trends in the use of "club drugs": an Australian review.
Degenhardt L; Copeland J; Dillon P
Subst Use Misuse; 2005; 40(9-10):1241-56. PubMed ID: 16048815
[TBL] [Abstract][Full Text] [Related]
5. [Effects of ecstasy on the body].
Saarijärvi S; Lopperi M
Duodecim; 2003; 119(13):1211-5. PubMed ID: 12908183
[No Abstract] [Full Text] [Related]
6. Club drugs: MDMA, gamma-hydroxybutyrate (GHB), Rohypnol, and ketamine.
Gahlinger PM
Am Fam Physician; 2004 Jun; 69(11):2619-26. PubMed ID: 15202696
[TBL] [Abstract][Full Text] [Related]
7. Cognitive deficits and cognitive normality in recreational cannabis and Ecstasy/MDMA users.
Parrott A
Hum Psychopharmacol; 2003 Mar; 18(2):89-90. PubMed ID: 12590401
[No Abstract] [Full Text] [Related]
8. Pharmacological aspects of the combined use of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and gamma-hydroxybutyric acid (GHB): a review of the literature.
Uys JD; Niesink RJ
Drug Alcohol Rev; 2005 Jul; 24(4):359-68. PubMed ID: 16234132
[TBL] [Abstract][Full Text] [Related]
9. [Psychiatric disorders and consumption of ecstasy drug (MDMA): review of published case reports].
Bango J; Fadón P; Mata F; Rubio G; Santo-Domingo J
Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1998; 26(4):260-3. PubMed ID: 9807860
[TBL] [Abstract][Full Text] [Related]
10. [Party drugs cause dangerous poisonings. Risk of serious complications and death].
Knudsen K
Lakartidningen; 2011 Feb 2-8; 108(5):207-11. PubMed ID: 21384618
[No Abstract] [Full Text] [Related]
11. Club drugs: reasons for and consequences of use.
Parks KA; Kennedy CL
J Psychoactive Drugs; 2004 Sep; 36(3):295-302. PubMed ID: 15559677
[TBL] [Abstract][Full Text] [Related]
12. The dark side of ecstasy: neuropsychiatric symptoms after exposure to 3,4-methylenedioxymethamphetamine.
Karlsen SN; Spigset O; Slørdal L
Basic Clin Pharmacol Toxicol; 2008 Jan; 102(1):15-24. PubMed ID: 18047478
[TBL] [Abstract][Full Text] [Related]
13. Qualitative review of serotonin syndrome, ecstasy (MDMA) and the use of other serotonergic substances: hierarchy of risk.
Silins E; Copeland J; Dillon P
Aust N Z J Psychiatry; 2007 Aug; 41(8):649-55. PubMed ID: 17620161
[TBL] [Abstract][Full Text] [Related]
14. Modelling the adverse effects associated with ecstasy use.
Fisk JE; Murphy PN; Montgomery C; Hadjiefthyvoulou F
Addiction; 2011 Apr; 106(4):798-805. PubMed ID: 21182557
[TBL] [Abstract][Full Text] [Related]
15. Methodological problems with ecstasy and the SCL-90.
Cole JC; Sumnall HR; Wagstaff GF
Psychopharmacology (Berl); 2002 Jul; 162(2):215-7; discussion 218-22. PubMed ID: 12110999
[No Abstract] [Full Text] [Related]
16. Club drugs: is it all ecstasy?
Tellier PP
Pediatr Ann; 2002 Sep; 31(9):550-6. PubMed ID: 12271739
[No Abstract] [Full Text] [Related]
17. [Poisoning with central nervous system stimulants. Amphetamine, ecstasy, cocaine and gamma-hydroxybutyrate].
Christensen HR
Ugeskr Laeger; 1999 Dec; 161(50):6899. PubMed ID: 10643372
[No Abstract] [Full Text] [Related]
18. Raves: a review of the culture, the drugs and the prevention of harm.
Weir E
CMAJ; 2000 Jun; 162(13):1843-8. PubMed ID: 10906922
[TBL] [Abstract][Full Text] [Related]
19. Club drug use in Germany.
Soellner R
Subst Use Misuse; 2005; 40(9-10):1279-93. PubMed ID: 16048817
[TBL] [Abstract][Full Text] [Related]
20. Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study.
de Sola Llopis S; Miguelez-Pan M; Peña-Casanova J; Poudevida S; Farré M; Pacifici R; Böhm P; Abanades S; Verdejo García A; Langohr K; Zuccaro P; de la Torre R
J Psychopharmacol; 2008 Jul; 22(5):498-510. PubMed ID: 18208910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
